Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), sold 17,503 shares at $24.13 ($418K) on 2021-06-16, disclosed to the SEC on 2021-06-21.
Open-market sale of $418k RCUS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.13 | 3,809 | $92K | 22.0% |
| 2 | $24.13 | 3,809 | $92K | 22.0% |
| 3 | $24.77 | 159 | $4K | 0.9% |
| 4 | $23.68 | 4,863 | $115K | 27.5% |
| 5 | $23.68 | 4,863 | $115K | 27.5% |
| Total | $23.89 avg | 17,503 |
| $418K |
| 100% |
| Filing → |
| RCUS | SELL | 2022-12-16 | $802K | — | Filing → |
| RCUS | SELL | 2022-06-21 | $350K | — | Filing → |
| RCUS | SELL | 2021-12-20 | $277K | — | Filing → |